ICARES Medicus, Inc. (TPEX:6612)
Taiwan
· Delayed Price · Currency is TWD 121.00
-0.50 (-0.41%)
Apr 2, 2025, 1:30 PM CST
ICARES Medicus Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 859.79 | 605.45 | 511.85 | 393.92 | 362.67 | Upgrade
|
| Revenue Growth (YoY) | 42.01% | 18.29% | 29.94% | 8.62% | -13.52% | Upgrade
|
| Cost of Revenue | 260.06 | 123.05 | 94.41 | 71.04 | 70.8 | Upgrade
|
| Gross Profit | 599.73 | 482.4 | 417.44 | 322.89 | 291.87 | Upgrade
|
| Selling, General & Admin | 277.97 | 186.31 | 157.23 | 127 | 116.32 | Upgrade
|
| Research & Development | 192.7 | 177.45 | 133.08 | 104.87 | 98.25 | Upgrade
|
| Operating Expenses | 476.48 | 373.84 | 292.73 | 235.03 | 213.36 | Upgrade
|
| Operating Income | 123.25 | 108.56 | 124.71 | 87.85 | 78.52 | Upgrade
|
| Interest Expense | -18.33 | -7.17 | -0.58 | -0.83 | -0.98 | Upgrade
|
| Interest & Investment Income | 44.45 | 5.29 | 2.67 | 2.48 | 1.5 | Upgrade
|
| Earnings From Equity Investments | 2.38 | -1.35 | -4.18 | -2.17 | -5.46 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.64 | 0.93 | 15.72 | -4.81 | -6.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.18 | 4.56 | 5.1 | 3.99 | 2.6 | Upgrade
|
| EBT Excluding Unusual Items | 165.58 | 110.82 | 143.44 | 86.51 | 69.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.17 | 2.47 | -0.33 | -13.32 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 4.02 | Upgrade
|
| Pretax Income | 164.4 | 113.29 | 143.11 | 73.19 | 73.76 | Upgrade
|
| Income Tax Expense | 109.89 | 48.86 | 32.72 | 35.82 | 36.84 | Upgrade
|
| Earnings From Continuing Operations | 54.51 | 64.43 | 110.39 | 37.37 | 36.93 | Upgrade
|
| Minority Interest in Earnings | 48.61 | 33.3 | 18.52 | 21.23 | 14.98 | Upgrade
|
| Net Income | 103.12 | 97.73 | 128.91 | 58.6 | 51.91 | Upgrade
|
| Net Income to Common | 103.12 | 97.73 | 128.91 | 58.6 | 51.91 | Upgrade
|
| Net Income Growth | 5.52% | -24.19% | 119.97% | 12.90% | -35.93% | Upgrade
|
| Shares Outstanding (Basic) | 43 | 38 | 37 | 37 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 39 | 37 | 37 | 37 | Upgrade
|
| Shares Change (YoY) | 11.53% | 2.91% | 0.74% | 0.38% | 0.39% | Upgrade
|
| EPS (Basic) | 2.41 | 2.55 | 3.46 | 1.58 | 1.41 | Upgrade
|
| EPS (Diluted) | 2.40 | 2.54 | 3.45 | 1.58 | 1.40 | Upgrade
|
| EPS Growth | -5.51% | -26.28% | 117.82% | 12.99% | -36.36% | Upgrade
|
| Free Cash Flow | -159.8 | -96.74 | 97.47 | 33.18 | 62.26 | Upgrade
|
| Free Cash Flow Per Share | -3.72 | -2.51 | 2.60 | 0.89 | 1.68 | Upgrade
|
| Dividend Per Share | 0.300 | 0.182 | 0.909 | 0.455 | 0.091 | Upgrade
|
| Dividend Growth | 65.02% | -80.00% | 100.02% | 400.00% | -80.00% | Upgrade
|
| Gross Margin | 69.75% | 79.68% | 81.56% | 81.97% | 80.48% | Upgrade
|
| Operating Margin | 14.34% | 17.93% | 24.37% | 22.30% | 21.65% | Upgrade
|
| Profit Margin | 11.99% | 16.14% | 25.19% | 14.88% | 14.31% | Upgrade
|
| Free Cash Flow Margin | -18.59% | -15.98% | 19.04% | 8.42% | 17.17% | Upgrade
|
| EBITDA | 180.13 | 129.33 | 142.69 | 106.87 | 99.58 | Upgrade
|
| EBITDA Margin | 20.95% | 21.36% | 27.88% | 27.13% | 27.46% | Upgrade
|
| D&A For EBITDA | 56.87 | 20.77 | 17.97 | 19.02 | 21.07 | Upgrade
|
| EBIT | 123.25 | 108.56 | 124.71 | 87.85 | 78.52 | Upgrade
|
| EBIT Margin | 14.34% | 17.93% | 24.37% | 22.30% | 21.65% | Upgrade
|
| Effective Tax Rate | 66.84% | 43.13% | 22.86% | 48.94% | 49.94% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.